Nanalysis Scientific (CVE:NSCI) Stock Price Down 19.6% – Should You Sell?

Nanalysis Scientific Corp. (CVE:NSCIGet Free Report) was down 19.6% during mid-day trading on Saturday . The stock traded as low as C$0.18 and last traded at C$0.19. Approximately 802,183 shares changed hands during mid-day trading, an increase of 866% from the average daily volume of 83,002 shares. The stock had previously closed at C$0.23.

Nanalysis Scientific Trading Down 19.6%

The firm has a market cap of C$20.95 million, a P/E ratio of -1.68 and a beta of -0.75. The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42. The firm has a fifty day moving average of C$0.24 and a 200-day moving average of C$0.27.

About Nanalysis Scientific

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.

Featured Articles

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.